Monday, May 25, 2026
ADVT 
International

UK opens second ballot for Young Professional visa scheme for Indians

Darpan News Desk IANS, 25 Jul, 2023 11:42 AM
  • UK opens second ballot for Young Professional visa scheme for Indians

London, July 25 (IANS) The UK government has announced the opening of the second ballot of the Young Professional Scheme for Indian citizens between 18 to 30 years of age.

The ballot, which opened on Monday, will close at 1.30 p.m. on Thursday, the British High Commission announced in a tweet.

The scheme, formally launched this year, allows Indian citizens with a graduate or postgraduate qualification to live and work in the UK for up to two years.

It allows the candidate to enter the UK at any time while their visa is valid, and leave and come back at any time during their stay. T

here are 3,000 places available for the India Young Professionals Scheme visa in 2023.

While most places were given in the first ballot which opened in February, the remaining places will be given in the July ballot.

Successful candidates in the ballot need to apply for their visa by the deadline given in a subsequent invitation to apply, which is usually within a month's period.

Also, they must travel to the UK within six months of applying for their visa.

The application fee charges have been set at 259 pounds and additional costs involved is a 940-pound healthcare surcharge and proof that the applicant has 2,530 pounds in personal savings.

To be eligible for the Young Professionals Scheme visa one must be an Indian national or citizen between 18 and 30 years old and have 2,530 pounds in savings to support themselves in the UK.

Also applicants should not have children under the age of 18 living with them or who they are financially responsible for.

MORE International ARTICLES

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine

Denmark pauses AstraZeneca vaccine jabs to probe blood clots

Denmark pauses AstraZeneca vaccine jabs to probe blood clots
Denmark's Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.

Denmark pauses AstraZeneca vaccine jabs to probe blood clots